跳至主要内容
临床试验/IRCT20180620040164N43
IRCT20180620040164N43招募中Unknown

Comparative bioequivalence study of Alprazolam 0.5 mg Tablet of Karen Pharma and Food Supplement Co. and Xanax® of Pfizer as reference in 24 healthy male under fasting conditions

Karen Pharma and Food Supplement Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
Male

入选标准

  • Healthy subjects (male) between 20-45 years of age and Body Mass Index (BMI) within 15% of normal range values between 18.5-30 (inclusive), calculated as Kg/m2.
  • Subjects with no significant diseases or abnormal findings during laboratory evaluations and clinical examination.
  • Subjects with normal vital signs.
  • Subjects who agree with patient consent form.

排除标准

  • Subjects with known allergy to the products tested.
  • Subjects who have narrow angle glaucoma or are taking strong CYP3A inhibitors.
  • History of cardiovascular, kidney, hepatic, muscular, metabolic, gastrointestinal (including constipation), neurologic, endocrine, hematopoietic (any kind of anemia), asthma, mental or organic disease.
  • Subjects suffering from muscular trauma 21 days before the beginning of the study.
  • Consumption of caffeine-containing products from 24 hour before dosing through 24 hour after administration.
  • Any clinically significant illness during the 4 weeks prior to the first study drug administration.
  • Hypotension (systolic blood pressure =90 millimeter Hg (mmHg) or diastolic blood pressure =60 mmHg) or hypertension (systolic blood pressure =130mmHg or diastolic blood pressure =90 mmHg).
  • Smoking more than 10 cigarettes per day and could not tolerate cigarette cessation during each clinical period.
  • Recent use of concomitant medication (prescription or over-the-counter) that could increase the risk of bleeding, or influence alprazolam pharmacokinetics.
  • History of alcohol or drug abuse.
  • Heavy drinker of caffeine, grapefruit juice or caffeinated drinks or who are on special diet (such as vegetarians) or do exertional physical activity.
  • A history of difficulty with donating blood or donation of more than 500 ml blood within 7 days prior to the start of the study.

研究者

发起方
Karen Pharma and Food Supplement Co.

相似试验